In part 1 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the safety of non-nutritive sweeteners.

In part 2 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the various users of low calorie sweeteners.

In part 3 of this Exclusive Interview, Judith Wylie-Rosett shares the results of trials studying the effects of using sweeteners in a conversation with Diabetes in Control Publisher Steve Freed.

In part 4 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the impact of artificial sweeteners on weight loss efforts as well as cardiometabolic health.

In part 5, the conclusion of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about her recommendations regarding talking about the use of sweeteners with patients who have diabetes. She also shares the highlights of her ADA presentation.

Food assistance may cut number of older adults with diabetes forgoing medications due to cost

Using higher HbA1c target in over-75s could increase disability-adjusted life-years by 44.2 percent

Diabetes in Control readers are being asked to participate in exclusive research that will provide new insights into what you think about insulin pumps and daily injections. Whether you’re a patient, a patient family member, medical professional or diabetes educator, we need to hear from you. Please take a few moments to take our survey and help our research. The survey takes only about 3 minutes, is completely anonymous, and lets you make your voice heard in analysis that can potentially influence the future of insulin delivery research and development.

Over the last 25 years, we have been looking for add-on therapies to help our type 1 patients control their glucose without increasing the risk of hypoglycemia. As we have gotten better insulins and monitoring devices, there has been an intensification of control and that often leads to greater changes …

The beta-cell preserving properties of short courses of metformin and insulin glargine evaluated in ever-growing population of patients who have diabetes.